相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel insights into the function ofCD24: A driving force in cancer
Peter Altevogt et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
The role of MET in chemotherapy resistance
Georgina E. Wood et al.
ONCOGENE (2021)
Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation
Andras Lanczky et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Expression of miR-181a in Circulating Tumor Cells of Ovarian Cancer and Its Clinical Application
Li Zuo et al.
ACS OMEGA (2021)
Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature
Xuhui Dong et al.
JOURNAL OF OVARIAN RESEARCH (2020)
MicroRNAs and Long Non-coding RNAs in c-Met-Regulated Cancers
Hong Zhan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients
Janos T. Fekete et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Ovarian Cancer Stem Cells: Role in Metastasis and Opportunity for Therapeutic Targeting
Xingyue Zong et al.
CANCERS (2019)
Presence and role of stem cells in ovarian cancer
Natasa Kenda Suster et al.
WORLD JOURNAL OF STEM CELLS (2019)
Cancer stem cell theory: Are we moving past the mist?
Kai-Feng Hung et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer
Shih-Hsuan Chan et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy
Shirin Eyvazi et al.
CURRENT CANCER DRUG TARGETS (2018)
Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
Jung Han Kim et al.
JOURNAL OF CANCER (2018)
c-Met inhibition enhances chemosensitivity of human ovarian cancer cells
Jing Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Ovarian cancer stem cells: still an elusive entity?
Michela Lupia et al.
MOLECULAR CANCER (2017)
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
Kiyoko Nakamura et al.
ONCOLOGY REPORTS (2017)
c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
Ha-Jeong Kim et al.
SCIENTIFIC REPORTS (2016)
Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors
Safia Salaria et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Regulation of Yin Yang 1 by Tyrosine Phosphorylation
Gary Z. Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition
Aditya Parikh et al.
NATURE COMMUNICATIONS (2014)
CD24 Induces Expression of the Oncomir miR-21 via Src, and CD24 and Src Are Both Post-Transcriptionally Downregulated by the Tumor Suppressor miR-34a
Santoshi Muppala et al.
PLOS ONE (2013)
Cancer stem cells and their role in metastasis
Yusuke Shiozawa et al.
PHARMACOLOGY & THERAPEUTICS (2013)
CD44+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
Erhong Meng et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Activation of c-MET Induces a Stem-Like Phenotype in Human Prostate Cancer
Geert J. L. H. van Leenders et al.
PLOS ONE (2011)
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Yunqing Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Controversies in Cancer Stem Cells: Targeting Embryonic Signaling Pathways
Naoko Takebe et al.
CLINICAL CANCER RESEARCH (2010)
CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
M-Q Gao et al.
ONCOGENE (2010)
c-Met Overexpression Contributes to the Acquired Apoptotic Resistance of Nonadherent Ovarian Cancer Cells through a Cross Talk Mediated by Phosphatidylinositol 3-Kinase and Extracellular Signal-Regulated Kinase 1/2
Maggie K. S. Tang et al.
NEOPLASIA (2010)
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
Nathan J. Bowen et al.
BMC MEDICAL GENOMICS (2009)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer
SA Bapat et al.
CANCER RESEARCH (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PROMO:: detection of known transcription regulatory elements using species-tailored searches
X Messeguer et al.
BIOINFORMATICS (2002)
Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome
MG Reese
COMPUTERS & CHEMISTRY (2001)
分享论文
